The Swiss Headache Society has certified us as a migraine friendly workplace. Those affected find a supportive working environment with us so that they can achieve their full potential.
After preliminary discussions and some preparation, we were subjected to a thorough and detailed assessment by members of the board of the Swiss Headache Society in November 2025. For over 30 years, the Swiss Headache Society (SKG) has been uniting specialists, primary care physicians and scientists dealing with the subject of headaches and migraines.
Migraines affect around 15 per cent of the working population. Creating a working environment in which migraine patients can develop their full potential and feel comfortable is therefore of great interest to AbbVie – on the one hand, because the well-being of our employees is central for us, and on the other, because it helps to reduce absenteeism at work and also counteracts so-called "presenteeism" (reduced work performance due to illness).
The Label of the Swiss Headache Society recognises companies that take an open approach to the condition and, through this acceptance and targeted measures, relieve and support those affected, thereby also reducing the stigma that migraine sufferers continue to suffer from greatly. This is because migraine is still far too often misjudged as a psychosomatic rather than a neurological illness.
The "Migraine Friendly Workspace" quality label from the Swiss Headache Society is based on three e pillars:
Dr. Michael Becker, Jennifer Heldner from AbbVie with Prof. Susanne Wegener, SKG
The AbbVie webpage you have requested is only intended for certain countries. (You will find the relevant information on the page.) Therefore, the website may contain information on medicinal products, other products or uses of these products that are not authorised in other countries or regions. If the latter applies to you, please contact your AbbVie national subsidiary to obtain the correct product information for your country. The AbbVie webpage you have requested is not in German. The AbbVie webpage you have requested may not be optimised for your screen size. Would you like to continue?